Home › Trials › NCT06087224

Telemedicine for neonatal resuscitation in community hospitals

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

NA · Mayo Clinic · NCT06087224

This study tests if using video calls with neonatologists can help improve the care and health outcomes for newborns in community hospitals who need immediate medical attention.

Quick facts

PhaseNA
Study typeInterventional
Enrollment947 (estimated)
Ages0 Days and up
SexAll
SponsorMayo Clinic (other)
Locations36 sites (Anchorage, Alaska and 35 other locations)
Trial IDNCT06087224 on ClinicalTrials.gov

What this trial studies

This multicenter trial evaluates the effectiveness of real-time audio-video telemedicine consults with neonatologists, known as teleneonatology, on improving health outcomes for at-risk neonates delivered in community hospitals. The study employs a stepped wedge cluster randomized design to assess the impact on early mortality and morbidity rates, as well as the quality of delivery room care. By integrating telemedicine into neonatal resuscitation practices, the trial aims to enhance the support available to clinicians in community settings.

Who should consider this trial

Good fit: Ideal candidates include at-risk neonates born in participating community hospitals, particularly those who are preterm or require advanced resuscitation.

Not a fit: Patients who are not born in participating community hospitals or do not meet the criteria for at-risk neonates may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly reduce early mortality and morbidity rates in at-risk neonates.

How similar studies have performed: Other studies have shown promising results with telemedicine in neonatal care, indicating potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

GROUP 1: Community hospital clinicians

To be eligible to participate in this study, an individual must meet all of the following criteria:

1. A clinician who attends newborn resuscitations at a participating community hospital spoke site.
2. Provision of informed oral consent prior to any mandatory study specific procedures and analyses.

GROUP 2: At-risk outborn neonates To be eligible for this study, a neonate born in a participating community hospital spoke site must meet \*at least one\* of the following inclusion criteria

1. Preterm birth at less than 32 weeks' gestation at delivery; OR
2. Need for advanced resuscitation defined as:

   1. positive pressure ventilation (PPV) initiated soon after birth and continued for at least 10 minutes; OR
   2. placement of an alternative airway (endotracheal tube or laryngeal mask) to provide PPV; OR
   3. chest compressions.

Exclusion Criteria:

GROUP 1: Community hospital clinicians None

GROUP 2: At-risk outborn neonates

A neonate born in a participating community hospital spoke site who meets any of the following criteria will be excluded from the study:

1. Birth outside of the hospital birthing center.
2. Neonatal transport team present at time of birth and providing resuscitative care.
3. Severe congenital anomaly necessitating intensive care or surgery in the first two weeks of life.
4. Plan for comfort care (non-resuscitation) following delivery.
5. In-person neonatology-trained physician present for the resuscitation.

Where this trial is running

Anchorage, Alaska and 35 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Death, Neonatal, Morbidity, Newborn, Telemedicine, Resuscitation

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.